Intraperitoneal pressure in peritoneal dialysis

被引:30
|
作者
Perez Diaz, Vicente [1 ,2 ]
Sanz Ballesteros, Sandra [1 ]
Hernandez Garcia, Esther [3 ]
Descalzo Casado, Elena [4 ]
Herguedas Callejo, Irene [4 ]
Ferrer Perales, Cristina [1 ]
机构
[1] Hosp Clin Univ Valladolid, Serv Nefrol, Valladolid, Spain
[2] Univ Valladolid, Fac Med, Dept Med Dermatol & Toxicol, Valladolid, Spain
[3] Complejo Asistencial Univ Palencia, Serv Nefrol, Palencia, Spain
[4] Univ Valladolid, Fac Med, Valladolid, Spain
来源
NEFROLOGIA | 2017年 / 37卷 / 06期
关键词
Intraperitoneal pressure; Hydrostatic pressure; Ultrafiltration; Ultrafiltration failure; Mechanical complications of; peritoneal dialysis; Infusion volume; FILL-VOLUME; ULTRAFILTRATION FAILURE; SOLUTE TRANSPORT; BODY-SIZE; CHILDREN; FLUID; IMPACT; CAPD; COMPLICATIONS; TOLERANCE;
D O I
10.1016/j.nefro.2017.05.014
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The measure of intraperitoneal pressure in peritoneal dialysis is easy and provides clear therapeutic benefits. However it is measured only rarely in adult peritoneal dialysis units. This review aims to disseminate the usefulness of measuring intraperitoneal pressure. This measurement is performed in supine before initiating the drain of a manual exchange with "Y" system, by raising the drain bag and measuring from the mid-axillary line the height of the liquid column that rises from the patient. With typical values of 10-16 cm H2O, intraperitoneal pressure should never exceed 18 cm H2O. With basal values that depend on body mass index, it increases 1-3 cm H2O/L of intraperitoneal volume, and varies with posture and physical activity. Its increase causes discomfort, sleep and breathing disturbances, and has been linked to the occurrence of leaks, hernias, hydrothorax, gastro-esophageal reflux and enteric peritonitis. Less known and valued is its ability to decrease the effectiveness of dialysis significantly counteracting ultrafiltration and decreasing solute clearance to a smaller degree. Because of its easy measurement and potential utility, should be monitored in case of ultrafiltration failure to rule out its eventual contribution in some patients. Although not yet mentioned in the clinical practice guidelines for PD, its clear benefits justify its inclusion among the periodic measurements to consider for prescribing and monitoring peritoneal dialysis. (c) 2017 Sociedad Espanola de Nefrologia. Published by Elsevier Espana,S.L.U.
引用
收藏
页码:579 / 586
页数:8
相关论文
共 50 条
  • [41] Intraperitoneal electrolytes in peritoneal dialysis: an alternative to oral supplements?
    Nature Clinical Practice Nephrology, 2007, 3 (10): : 526 - 527
  • [42] SUBCUTANEOUS INTRAPERITONEAL PROSTHESIS FOR MAINTENANCE PERITONEAL-DIALYSIS
    GOTLOIB, L
    NISENCORN, I
    GARMIZO, AL
    GALILI, N
    SERVADIO, C
    SUDARSKY, M
    LANCET, 1975, 1 (7920): : 1318 - 1319
  • [43] Pharmacokinetics of Intraperitoneal Vancomycin in Patients on Automated Peritoneal Dialysis
    Lam, Edwin
    Kraft, Walter K.
    Stickle, Douglas F.
    Piraino, Beth M.
    Zhang, JingJing
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 336 - 336
  • [44] Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients
    Moberly, JB
    Sorkin, M
    Kucharski, A
    Ogle, K
    Mongoven, J
    Skoufos, L
    Lin, L
    Bailey, S
    Rodela, H
    Mupas, L
    Walele, A
    Ogrinc, F
    White, D
    Wolfson, M
    Martis, L
    Breborowicz, A
    Oreopoulos, DG
    PERITONEAL DIALYSIS INTERNATIONAL, 2003, 23 (01): : 63 - 73
  • [45] Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients
    Sjoland, JA
    Pedersen, RS
    Jespersen, J
    Gram, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) : 1264 - 1268
  • [46] Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis
    Pawlaczyk, K
    Kuzlan-Pawlaczyk, M
    Anderstam, B
    Heimbürger, O
    Bergström, J
    Waniewski, J
    Breborowicz, A
    Lindholm, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) : 669 - 671
  • [47] Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis
    Dahl, NV
    Foote, EF
    Searson, KM
    Fein, JL
    Kapoian, T
    Steward, CA
    Sherman, RA
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (12) : 1284 - 1289
  • [48] URIC ACID INDUCES INTRAPERITONEAL INFLAMMATION IN PERITONEAL DIALYSIS PATIENTS
    Stepanova, Natalia
    Burdeyna, Olena
    Driianska, Victoria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [49] Intraperitoneal thrombolytic therapy for peritoneal dialysis-associated peritonitis
    Worland, MA
    Radabaugh, RS
    Mueller, BA
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (11) : 1216 - 1220
  • [50] Comparison of intraperitoneal and subcutaneous epoetin alfa in peritoneal dialysis patients
    Johnson, CA
    Wakeen, M
    Taylor, CA
    Zimmerman, SW
    Burkart, J
    Bhattacharya, A
    Kosorok, MR
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (06): : 578 - 582